Invesco Biotechnology & Genome ETF (PBE) Holdings List

$98.72 +0.04 (+0.04%)

As of 09/3/2026 04:10 PM Eastern

What stocks does PBE hold?

The Invesco Biotechnology & Genome ETF (PBE) top stock holdings include Regeneron Pharmaceuticals, Amgen, and Vertex Pharmaceuticals. The top 25 PBE holdings ordered by weight make up 90.26% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PBE Holdings

Rank	Company	Current Price	Weight	Shares Held
1	REGN Regeneron Pharmaceuticals	$843.47 -1.0%	5.44%	25,865
2	AMGN Amgen	$444.12 +0.3%	5.36%	48,871
3	VRTX Vertex Pharmaceuticals	$557.96 +0.2%	5.23%	37,732
4	CDNA CareDx	$49.86 +0.5%	5.19%	415,995
5	RPRX Royalty Pharma	$63.88 +1.2%	4.76%	305,038
6	BIIB Biogen	$224.51 +0.8%	4.69%	85,075
7	GILD Gilead Sciences	$151.22 +1.1%	4.40%	122,866
8	UTHR United Therapeutics	$490.24 -0.4%	3.83%	28,357
9	PTGX Protagonist Therapeutics	$148.80 +1.9%	3.59%	89,591
10	TECH Bio-Techne	$72.45 +0.2%	3.56%	186,851
Get the Latest News and Ratings for PBE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.
11	HALO Halozyme Therapeutics	$110.76 +1.0%	3.50%	130,441
12	RGEN Repligen	$169.61 -1.9%	3.40%	77,791
13	ALNY Alnylam Pharmaceuticals	$264.50 -1.1%	3.28%	55,601
14	ACAD ACADIA Pharmaceuticals	$27.86 -3.7%	3.27%	421,512
15	BMRN BioMarin Pharmaceutical	$66.43 -0.8%	3.14%	169,509
16	ILMN Illumina	$221.66 +3.9%	3.14%	61,695
17	VCEL Vericel	$40.47 -1.0%	3.02%	256,266
18	BCRX BioCryst Pharmaceuticals	$10.09 -0.8%	2.96%	1,057,963
19	INCY Incyte	$128.00 -0.6%	2.94%	92,288
20	QGEN Qiagen	$43.80 -0.9%	2.86%	252,175
21	OMER Omeros	$19.11 +1.3%	2.78%	769,229
22	SRPT Sarepta Therapeutics	$22.99 -0.9%	2.61%	537,572
23	PTCT PTC Therapeutics	$71.40 -0.5%	2.54%	132,493
24	VCYT Veracyte	$44.67 -0.5%	2.39%	202,699
25	EXEL Exelixis	$59.13 +1.0%	2.38%	179,304

PBE Geographic Exposure

PBE's largest geographic exposure is United States at 97.2%, followed by Netherlands at 2.8%.

United States
97.2%
Netherlands
2.8%

PBE Currency Exposure

PBE is exclusively exposed to USD.

USD
94.4%

PBE Sector Exposure

PBE's largest sector exposure is Health Care at 97.2%.

Health Care
97.2%

PBE Industry Exposure

PBE's largest industry exposure is Biotechnology at 82.3%, followed by Health Care Equipment & Supplies at 10.1%.

Biotechnology
82.3%
Health Care Equipment & Supplies
10.1%
Health Care Providers & Services
4.8%

PBE Sub-Industry Exposure

PBE's largest sub-industry exposure is Biotechnology at 82.3%, followed by Life Sciences Tools & Services at 10.1%.

Biotechnology
82.3%
Life Sciences Tools & Services
10.1%
Health Care Services
4.8%

Related Companies and Tools

Related Companies

MarketBeat tracks Invesco Biotechnology & Genome ETF holdings and portfolio composition, last updated on 8/27/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invesco Biotechnology & Genome ETF (PBE) Holdings List